Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;6(1-2):55-64.
doi: 10.1615/ForumImmunDisTher.2016014169.

A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey

Jonathan M Kagan  1 , Ana M Sanchez  2 , Alan Landay  3 , Thomas N Denny  2
Affiliations

A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey

Jonathan M Kagan et al. For Immunopathol Dis Therap. 2015.

Abstract

Foundational cellular immunology research of the 1960s and 1970s, together with the advent of monoclonal antibodies and flow cytometry, provided the knowledge base and the technological capability that enabled the elucidation of the role of CD4 T cells in HIV infection. Research identifying the sources and magnitude of variation in CD4 measurements, standardized reagents and protocols, and the development of clinical flow cytometers all contributed to the feasibility of widespread CD4 testing. Cohort studies and clinical trials provided the context for establishing the utility of CD4 for prognosis in HIV-infected persons, initial assessment of in vivo antiretroviral drug activity, and as a surrogate marker for clinical outcome in antiretroviral therapeutic trials. Even with sensitive HIV viral load measurement, CD4 cell counting is still utilized in determining antiretroviral therapy eligibility and time to initiate therapy. New point of care technologies are helping both to lower the cost of CD4 testing and enable its use in HIV test and treat programs around the world.

Keywords: CD4; HIV/AIDS; biomarkers; flow cytometry; immune monitoring.

PubMed Disclaimer

References

    1. Cantor H, Shen FW, Boyse EA. Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med. 1976;143(6):1382–1390. - PMC - PubMed
    1. Gershon RK. T cell control of antibody production. Contemp Top Immunobiol. 1974;3:1–40. - PubMed
    1. Chess L, MacDermott RP, Schlossman SF. Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens. J Immunol. 1974;113(4):1113–1121. - PubMed
    1. Choi YS, Good RA. Development of chicken lymphoid system. I. Synthesis and secretion of immunoglobulins by chicken lymphoid cells. J Exp Med. 1972;135(5):1133–1150. - PMC - PubMed
    1. Reinherz EL, Schlossman SF. The differentiation and function of human T lymphocytes. Cell. 1980;19(4):821–827. - PubMed

LinkOut - more resources